Reply to the Editor— Functional substrate mapping of ventricular arrhythmia
Konstantinos Vlachos, Antonio Frontera, Karim Benali, Konstantinos P. Letsas, Pierre Jais, Pasquale Santangeli

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCardiac Arrhythmias and Treatments · Cardiac electrophysiology and arrhythmias · Atrial Fibrillation Management and Outcomes
Outcomes from ventricular tachycardia (VT) ablation vary significantly, with an average freedom from appropriate implantable cardioverter-defibrillator therapy of 72% for ablation compared with 60% for medical therapy in major randomized trials.1^,^2 These findings underscore the limitations of current ablation strategies, which fall short of optimal success rates that might improve nonarrhythmic outcomes such as mortality. However, VT ablation has demonstrated benefits, including reduced hospitalization, improved quality of life, and greater cost-effectiveness. It is important to note that real-world outcomes may be worse than those observed in controlled trial settings, emphasizing the need for advancements in ablation techniques. In this context, our review focuses on functional substrate mapping approaches to improve the identification of abnormal VT substrates in patients with structural heart disease.
We appreciate the thoughtful comments from Drs Hsia and Choi and agree that further investigations are needed to determine the optimal activation wavefront for substrate mapping, which varies depending on substrate location. For example, Shinoda et al3 elegantly demonstrated that rotational activation patterns (RAPs) around localized conduction blocks are often associated with critical VT zones. The direction of the activation wavefront significantly affects the manifestation of RAP and the location of lines of block (LOBs). Pacing near the scar can enhance identification of critical VT zones, but the optimal rhythm for substrate mapping depends on the spatial distribution of the target substrate.3 RAPs and LOBs are more apparent when the wavefront is perpendicular to the LOBs, particularly when delayed conduction is present on one side. However, when multiple wavefronts collide late in the activation process, identifying RAPs and LOBs becomes challenging.
Practically, the activation wavefront chosen for substrate mapping is often based on the preprocedural imaging distribution of the abnormal substrate. For anterior left ventricular (LV) scars, sinus rhythm or right ventricular (RV) pacing is preferred; for septal LV scars, RV basal pacing is used; and for lateral LV scars, LV pacing from a coronary sinus branch is optimal. However, substrates involving both septal and lateral components may require multiple wavefronts to comprehensively identify slow conduction and block areas. Studies demonstrated that pacing from RV and LV sites can reveal an additional 25% of critical VT sites not evident during sinus rhythm mapping.4^,^5 Moreover, Nishimura et al6 showed that differential pacing can uncover concealed LOBs in 84% of regions without overt LOBs during baseline rhythms, highlighting the importance of pacing in regions of slow conduction.
Preemptive identification of isthmus boundaries during sinus or paced rhythms could simplify VT ablation, reduce the need for VT induction, and enhance procedural safety. In addition, accurate electrogram annotation is critical to mapping. Advances in automated annotation algorithms, such as optimization decremented evoked potential mapping annotation, could further refine substrate mapping.
Future developments may include integrating imaging modalities such as magnetic resonance imaging or computed tomography to identify arrhythmogenic substrates preprocedurally. These tools can guide substrate mapping, particularly in areas of scar tissue or lipomatous metaplasia, which are known to support VT reentry circuits. Another promising avenue for investigation is the role of repolarization heterogeneity in VT maintenance. For instance, Callans and Donahue7 found shorter activation-recovery intervals within the VT circuit isthmus compared with other regions, suggesting that disparities in repolarization may be key to sustaining VT. Investigating both depolarization abnormalities and repolarization heterogeneity could open new therapeutic avenues.
Finally, we thank Drs Hsia and Choi for their constructive feedback regarding Figures 1 and 3. A corrigendum will be issued in line with their suggestions to improve clarity and accuracy. We sincerely apologize for any oversights in the initial submission and are grateful for their contributions to refining our manuscript.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Della Bella P.Baratto F.Vergara P.Does timing of ventricular tachycardia ablation affect prognosis in patients with an implantable cardioverter defibrillator? Results from the multicenter randomized PARTITA trial Circulation 1452022182918383536970010.1161/CIRCULATIONAHA.122.059598 · doi ↗ · pubmed ↗
- 2Kuck K.H.Schaumann A.Eckardt L.Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial Lancet 375201031402010986410.1016/S 0140-6736(09)61755-4 · doi ↗ · pubmed ↗
- 3Shinoda Y.Komatsu Y.Hattori M.Optimal cardiac rhythm during substrate mapping in scar-related ventricular tachycardia: significance of wavefront direction on identifying critical sites Heart Rhythm 212024129813073843242510.1016/j.hrthm.2024.02.060 · doi ↗ · pubmed ↗
- 4Anter E.Kleber A.G.Rottmann M.Infarct-related ventricular tachycardia: redefining the electrophysiological substrate of the isthmus during sinus rhythm JACC Clin Electrophysiol 42018103310483013948510.1016/j.jacep.2018.04.007 · doi ↗ · pubmed ↗
- 5Martin C.A.Martin R.Maury P.Effect of activation wavefront on electrogram characteristics during ventricular tachycardia ablation Circ Arrhythm Electrophysiol 122019 e 00729310.1161/CIRCEP.119.00729331122054 · doi ↗ · pubmed ↗
- 6Nishimura T.Shatz N.Weiss J.P.Identification of human ventricular tachycardia demarcated by fixed lines of conduction block in a 3-dimensional hyperboloid circuit Circulation 1482023135413673763838910.1161/CIRCULATIONAHA.123.065525 · doi ↗ · pubmed ↗
- 7Callans D.J.Donahue J.K.Repolarization heterogeneity in human post-infarct ventricular tachycardia JACC Clin Electrophysiol 820227137183573884610.1016/j.jacep.2022.03.002PMC 9236155 · doi ↗ · pubmed ↗
